Global Health Investment Corporation

News

GHIC is pleased to share our latest announcements, partnerships, investments, and new funds.

May 26 2026

Lilly to Acquire Vaccine Company, a Portfolio Company of GHIC’s Global Health Security Fund

May 21 2026

GHIC Announces the Launch of the Global Health Security Fund with $353M in Commitments

May 20 2026

GHIC Announces $10M Investment in Aerska to Advance Systemic Delivery of RNA Medicines to the Brain

Mar 30 2026

Centivax Secures $37M to Accelerate Universal Flu Clinical Development and Advance Pipeline

Mar 26 2026

Terrestrial Bio (formerly Vaxess Technologies) Raises $50M Series C to Advance Microarray Patch Platform

Mar 10 2026

GHIC Selected to 2026 ImpactAssets 50 Fund Managers

Feb 3 2026

GHIC Invests in Prenosis as Company Secures $20M Series A and $20M BARDA Contract to Advance Precision Diagnostics and Therapeutics

Jan 28 2026

GHIC Portfolio Company Antheia Raises Additional $24M, Bringing Series C to $80M Funded

Nov 20 2025

GHIC’s Catalytic Health Investment Platform and BlueMark Announce Partnership to Strengthen Impact Capabilities of Fund Managers Accelerating Healthcare Innovation in Low- and Middle-Income Countries

Oct 29 2025

Resilience Secures Up to $825M in Long-Term Financing to Accelerate CDMO Strategy

Jul 24 2025

GHIC invests in Verge HealthTech Fund II through the Catalytic Health Investment Platform

Jul 8 2025

Centivax Raises $45M Series A to Advance Universal Flu Vaccine into the Clinic

Jun 11 2025

GHIC Selected to 2025 ImpactAssets 50 Fund Managers

Jun 4 2025

GHIC Co-Leads Antheia’s $56M Series C Financing to Strengthen Resilience in Critical Drug Supply Chains

Apr 22 2025

Biolinq Closes $100M Series C Financing to Advance Its Biowearable Platform

Jan 28 2025

Medicines Development for Global Health (MDGH) Announces Ghana Health Service Rollout of Moxidectin, a New Treatment for River Blindness

Jan 16 2025

Micron Biomedical Extends Series A Financing to $33+M to Accelerate Commercialization of Needle-Free Therapeutics and Vaccines

Oct 28 2024

GHIC Launches the Frontier Fund to Seed New Innovations to Develop Novel Medical Countermeasures

Oct 10 2024

GHIC Invests in Cytovale’s $100M Series D to Accelerate Commercial Expansion of its Rapid Sepsis Solution

Oct 9 2024

GHIC invests in AfricInvest's Transform Health Fund Through the Newly Launched Catalytic Health Investment Platform